A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
11/2001
11/29/2001	CA2408709A1 Mannich base prodrugs of 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives and their use a modulators of protein kinases
11/29/2001	CA2408562A1 Dehydroascorbic acid formulations and uses thereof
11/29/2001	CA2408141A1 Neurotransmitter transporters
11/29/2001	CA2408140A1 G-protein coupled receptors
11/29/2001	CA2408125A1 Synthetic peptides and uses therefore
11/29/2001	CA2407570A1 Compositions and methods for delivery of a molecule into a cell
11/29/2001	CA2380935A1 Caspase inhibitors and uses thereof
11/28/2001	EP1158050A1 Human cysteinyl leukotriene receptor (CysLT2)
11/28/2001	EP1158002A1 Human G-protein coupled receptor
11/28/2001	EP1157997A1 Novel dipeptide compound and medicinal use thereof
11/28/2001	EP1157700A1 Anti-hiv agent
11/28/2001	EP1157698A2 Treatment of inflammatory diseases with oxypurine nucleosides
11/28/2001	EP1157275A1 Novel transduction molecules and methods for using same
11/28/2001	EP1157126A1 Method for cloning signal transduction intermediates
11/28/2001	EP1157123A1 Stable recombinant influenza viruses free of helper viruses
11/28/2001	EP1157121A1 Prrsv vaccines
11/28/2001	EP1157094A2 Method for the purification, recovery, and sporulation of cysts and oocysts
11/28/2001	EP1157030A1 Echinocandin/carbohydrate complexes
11/28/2001	EP1157024A1 Acetylenic ortho-sulfonamido and phosphinic acid amido bicyclic heteroaryl hydroxamic acids as tace inhibitors
11/28/2001	EP1156825A2 Immunogens comprising a peptide and a carrier derived from h.influenzae protein d
11/28/2001	EP1156820A1 Vascular endothelial growth factor-2
11/28/2001	EP1156817A1 Controlling protein levels in eucaryotic organisms
11/28/2001	EP1156813A2 Reovirus for the treatment of cellular proliferative disorders
11/28/2001	EP1156797A2 Synergistic inhibition of viral replication by long-chain hydrocarbons and nucleoside analogs
11/28/2001	EP1156794A1 Methods and compositions for the treatment of neuropathic pain, tinnitus, and other disorders using r(-)-ketoprofen
11/28/2001	EP1156791A1 Bupropion to treat viral diseases
11/28/2001	EP1156784A1 Processes for making pharmaceutical oral ecb formulations and compositions
11/28/2001	EP1156782A1 Echinocandin pharmaceutical formulations containing micelle-forming surfactants
11/28/2001	EP1156771A2 Interferon tau mutants and methods for making them
11/28/2001	EP1156717A1 A recombinant polypeptide for use in the manufacture of vaccines against campylobacter induced diarrhea and to reduce colonization
11/28/2001	EP0994878B1 Quinolone carboxylic acid derivatives
11/28/2001	EP0837845B1 Herpes ribonucleotide reductase inhibitors
11/28/2001	EP0804469B1 T-cell affecting peptides
11/28/2001	EP0783520B1 Broadly reactive opsonic antibodies reactive with common staphylococcal antigens
11/28/2001	EP0758244B1 Controlled-release dosage forms of azithromycin
11/28/2001	EP0695303B1 Pyridinium salts and their use for controlling helicobacter bacteria
11/28/2001	CN1324403A PRV-1 gene and the use thereof
11/28/2001	CN1324400A Method of screening for large offspring syndrome
11/28/2001	CN1324363A Calcium (3S) tetrahydro-3-furanyl (1S, 2R)-3-[[(4-aminophenyl)sulfonyl] (isobutyl) amino]-1-benzyl-2-(phosphonooxy) propylcarbamate
11/28/2001	CN1324353A Amidine derivatives, their preparation and application as medicines and pharmaceutical compositions containing same
11/28/2001	CN1324350A Benzoylpyridazines
11/28/2001	CN1324348A TAN-1057 derivatives
11/28/2001	CN1324258A Aglyco products and method of use
11/28/2001	CN1324250A Method for treating or preventing viral infections and associated diseases
11/28/2001	CN1324247A Process and materials for the repid detection of i(streptococcus pneumoniae) employing purified antigen-specific antibodies
11/28/2001	CN1324245A Activation and protection of T-cells (CD4+ and CD8+) using and H2 receptor agonist and other T-cell activating agents
11/28/2001	CN1324244A Methods for treating sepsis
11/28/2001	CN1324237A Method for improving pharmacokinetics of tipranavir
11/28/2001	CN1324212A Method for treating or preventing viral infections and associated diseases
11/28/2001	CN1323793A Schizonepeta lactone and its extraction process and use
11/28/2001	CN1323615A Bathing talcum powder
11/28/2001	CN1323605A Antibiotics obtaining method via plant immunity
11/28/2001	CN1323604A Foamed disease-treating ointment
11/28/2001	CN1323603A Cold-preventing and spleen-invigorating paste
11/28/2001	CN1075500C Process of prepn. novel coumaric quinolone carboxylic acid and uses thereof
11/28/2001	CN1075499C Quninolone-acid naphthyridone carboxylic acid derivatives
11/27/2001	US6323242 Treatment of disorders secondary to organic impairments
11/27/2001	US6323213 Possibly substituted 8-cyano-1-cyclopropyl-7-(2,8-diazabicyclo-[4.3.0]-nonan-8-yl)-6-fluoro-1,4-dihydro-4-oxo-3-quinolin carboxylic acids and their derivatives
11/27/2001	US6323210 Transferase inhibitor
11/27/2001	US6323206 Antiinflammatory agents and viricides for aids with cytokinesand chemokines
11/27/2001	US6323202 Benzamide substitutes with ketone compounds as enzyme inhibitors
11/27/2001	US6323200 The compounds are immunomodulators and induce cytokine biosynthesis, including interferon and/or tumor biosynthesis, necrosis factor, and inhibit the t-helper-type 2 immune response.
11/27/2001	US6323180 Protease inhibitors; inhibit replication of hepatitis c virus
11/27/2001	US6323176 Cyclic peptide antifungal agents
11/27/2001	US6323024 Plasmids for the expression of heterologus genes; for use in treatment and prevention of viral diseases
11/27/2001	US6323012 Method for treating viral infections
11/27/2001	US6322967 Recombinant tryptophan mutants of influenza
11/27/2001	US6322825 Compositions containing thymol and carvacrol and methods of treating gastrointestinal infections with the compositions
11/27/2001	US6322806 Over-coated chewing gum formulations including tableted center
11/27/2001	US6322793 Replacement of gene 50 glycoprotein with foreign genetic material
11/27/2001	US6322790 Treatment of primary and metastatic noeplastic diseases and infectious diseases; administering antigen presenting cells sensitized with complexes of hsps noncovalently bound to an antigenic molecule
11/27/2001	US6322780 Marek's disease virus vaccines for protection against Marek's disease
11/27/2001	CA2079685C Synthetic membrane vesicles containing functionally active fusion peptides as drug delivery systems
11/22/2001	WO2001088180A2 Tnf and ifn stimulated genes and uses therefor
11/22/2001	WO2001088161A1 Vector for analysing replication mechanism of rna virus and use thereof
11/22/2001	WO2001088132A2 Rabies virus-specific neutralizing human monoclonal antibodies and nucleic acids and related methods
11/22/2001	WO2001088128A1 Ssa-56kda polypeptide and its fragments and polynucleotides encoding said polypeptides and therapeutic uses
11/22/2001	WO2001088126A2 REGULATION OF HUMAN α1Α ADRENERGIC RECEPTOR-LIKE G PROTEIN-COUPLED RECEPTOR
11/22/2001	WO2001088108A1 Neuronal serine-threonine protein kinase
11/22/2001	WO2001088106A2 Novel deoxyribonucleside kinase enzyme multi-substrate variants
11/22/2001	WO2001088097A1 Immune potentiating compositions
11/22/2001	WO2001087895A1 Synthetic process for the manufacture of an ecteinaschidin compound
11/22/2001	WO2001087894A1 Antitumoral analogs of et-743
11/22/2001	WO2001087893A1 Process for preparing a pure, pharmacopoeial grade amorphous form of cefuroxime axetil
11/22/2001	WO2001087883A1 Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity
11/22/2001	WO2001087870A1 Hydroxamic acid derivatives
11/22/2001	WO2001087849A2 Modulators of tnf- alpha signaling
11/22/2001	WO2001087846A2 Tricyclic pyrazole derivatives as protein kinase inhibitors
11/22/2001	WO2001087844A1 Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity
11/22/2001	WO2001087839A1 Pharmaceutically active piperidine derivatives, in particular as modulators of chemokine receptor activity
11/22/2001	WO2001087828A1 N-substituted peptidyl nitriles as cysteine cathepsin inhibitors
11/22/2001	WO2001087824A2 7-substituted fused ring tetracycline compounds
11/22/2001	WO2001087823A1 Novel aryl, alkenyl, and alkynl 4-dedimethylaminotetracycline derivatives
11/22/2001	WO2001087810A1 Methods for the production of d-chiro-inositol and the use of d-chiro-inositol obtained therefrom
11/22/2001	WO2001087348A2 Multifunctional nanodevice platform
11/22/2001	WO2001087343A2 Combination therapy using cox-2 selective inhibitor and thromboxane inhibitor and compositions therefor
11/22/2001	WO2001087333A2 Immune system stimulating means
11/22/2001	WO2001087332A1 Compositions and methods for treatment of mucosal infections
11/22/2001	WO2001087330A2 Compositions and methods for achieving immune suppression
11/22/2001	WO2001087329A1 Liquid pharmaceutical composition containing an erythropoietin derivate

1 ... 1346 1347 1348 1349 1350 1351 1352 1353 1354 1355 1356 1357 1358 1359 1360 1361 1362 1363 1364 1365 1366 ... 1798